STIM - ニュ―ロネティクス (Neuronetics Inc.)

STIMのニュース

   Nerve Stimulator Market With Leading Players like Medtronic PLC, Cyberonics, Boston Scientific Corporation, St. Jude Medical, Nevro Corporation, ANM Adaptive Neuromodulation, BioControl Medical, Cerebomed, Neuronetics, Neuropace, Neuropace, Nevro  2020/11/19 05:13:42 OpenPR
The electrical nerve stimulation procedure uses a nerve stimulator, which treats chronic pain with an electrical current. A nerve stimulator set at low intensity is used to monitor the status of relevant nerves to ensure they still transmit promptly and
   The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration  2020/11/17 13:31:52 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 16) Aligos Therapeutics Inc (NASDAQ: ALGS ) (announced multiple presentations at the Liver Meeting) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Champions Oncology Inc (NASDAQ: CSBR ) CureVac BV (NASDAQ: CVAC )(announced a vaccine supply deal with the European Commission) Eidos Therapeutics Inc (NASDAQ: EIDX ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Kazia Therapeutics Ltd (NASDAQ: KZIA ) Keros Therapeutics Inc (NASDAQ: KROS ) Moderna Inc (NASDAQ: MRNA ) ( announced positive interim efficacy data for the Phase 3 study of its coronavirus vaccine candidate) Myokardia Inc (NASDAQ: MYOK ) Neuronetics Inc (NASDAQ: STIM ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Oncorus Inc (NASDAQ: ONCR ) Pacira Biosciences Inc (NASDAQ: PCRX ) Shockwave Medical Inc (NASDAQ: SWAV ) Spruce Biosciences Inc (NASDAQ: SPRB ) Summit Therapeutics Inc (NASDAQ: SMMT ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Tcr2 Therapeutics Inc (NASDAQ: TCRR ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) (announced regulatory filing for envafolimab in the indication of MSI-H/dMMR cancer, in China) Trinity Biotech plc (NASDAQ: TRIB ) United Therapeutics Corporation (NASDAQ: UTHR ) Veracyte Inc (NASDAQ: VCYT ) Vericel Corp (NASDAQ: VCEL ) Zai Lab Ltd – ADR (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov.
   Earnings Scheduled For November 2, 2020  2020/11/02 12:55:36 Benzinga
Companies Reporting Before The Bell • Itron (NASDAQ: ITRI ) is likely to report quarterly earnings at $0.25 per share on revenue of $540.01 million. • AMC Networks (NASDAQ: AMCX ) is projected to report quarterly earnings at $1.28 per share on revenue of $606.04 million. • BWX Technologies (NYSE: BWXT ) is likely to report quarterly earnings at $0.68 per share on revenue of $499.24 million. • Clorox (NYSE: CLX ) is projected to report quarterly earnings at $2.32 per share on revenue of $1.75 billion. • Camping World Holdings (NYSE: CWH ) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.51 billion. • Eagle Pharmaceuticals (NASDAQ: EGRX ) is likely to report quarterly earnings at $0.28 per share on revenue of $47.02 million. • Exterran (NYSE: EXTN ) is likely to report quarterly loss at $0.48 per share on revenue of $194.32 million. • FirstEnergy (NYSE: FE ) is likely to report quarterly earnings at $0.76 per share on revenue of $2.94 billion. • MGM Growth Properties (NYSE: MGP ) is expected to report quarterly earnings at $0.
   Neurostimulation Devices Market Top Key Players- Medtronic plc, NeuroPace Inc., Nevro Corporation, Neuronetics Inc. Growth Trends, quantitative analysis Industry Analysis and Market Dynamics of the Global Market, 2020 to 2027  2020/10/27 11:13:54 OpenPR
Summary of the Neurostimulation Devices Market Report Due to the various economic, technological, research & development and geographical aspects, the Neurostimulation Devices Market would gain a healthy CAGR and market size from 2020 to 2027. The growth trend would continue to
   Neurostimulation Devices Market Top Key Players- Nevro Corporation, Neuronetics Inc., NeuroSigma, Inc., Synapse Biomedical Inc Growth Trends, quantitative analysis Industry Analysis and Market Dynamics of the Global Market, 2020 to 2027  2020/10/27 11:08:42 OpenPR
Summary of the Neurostimulation Devices Market Report Due to the various economic, technological, research & development and geographical aspects, the Neurostimulation Devices Market would gain a healthy CAGR and market size from 2020 to 2027. The growth trend would
   The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration  2020/11/17 13:31:52 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 16) Aligos Therapeutics Inc (NASDAQ: ALGS ) (announced multiple presentations at the Liver Meeting) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Champions Oncology Inc (NASDAQ: CSBR ) CureVac BV (NASDAQ: CVAC )(announced a vaccine supply deal with the European Commission) Eidos Therapeutics Inc (NASDAQ: EIDX ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Kazia Therapeutics Ltd (NASDAQ: KZIA ) Keros Therapeutics Inc (NASDAQ: KROS ) Moderna Inc (NASDAQ: MRNA ) ( announced positive interim efficacy data for the Phase 3 study of its coronavirus vaccine candidate) Myokardia Inc (NASDAQ: MYOK ) Neuronetics Inc (NASDAQ: STIM ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Oncorus Inc (NASDAQ: ONCR ) Pacira Biosciences Inc (NASDAQ: PCRX ) Shockwave Medical Inc (NASDAQ: SWAV ) Spruce Biosciences Inc (NASDAQ: SPRB ) Summit Therapeutics Inc (NASDAQ: SMMT ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Tcr2 Therapeutics Inc (NASDAQ: TCRR ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) (announced regulatory filing for envafolimab in the indication of MSI-H/dMMR cancer, in China) Trinity Biotech plc (NASDAQ: TRIB ) United Therapeutics Corporation (NASDAQ: UTHR ) Veracyte Inc (NASDAQ: VCYT ) Vericel Corp (NASDAQ: VCEL ) Zai Lab Ltd – ADR (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov.
   Earnings Scheduled For November 2, 2020  2020/11/02 12:55:36 Benzinga
Companies Reporting Before The Bell • Itron (NASDAQ: ITRI ) is likely to report quarterly earnings at $0.25 per share on revenue of $540.01 million. • AMC Networks (NASDAQ: AMCX ) is projected to report quarterly earnings at $1.28 per share on revenue of $606.04 million. • BWX Technologies (NYSE: BWXT ) is likely to report quarterly earnings at $0.68 per share on revenue of $499.24 million. • Clorox (NYSE: CLX ) is projected to report quarterly earnings at $2.32 per share on revenue of $1.75 billion. • Camping World Holdings (NYSE: CWH ) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.51 billion. • Eagle Pharmaceuticals (NASDAQ: EGRX ) is likely to report quarterly earnings at $0.28 per share on revenue of $47.02 million. • Exterran (NYSE: EXTN ) is likely to report quarterly loss at $0.48 per share on revenue of $194.32 million. • FirstEnergy (NYSE: FE ) is likely to report quarterly earnings at $0.76 per share on revenue of $2.94 billion. • MGM Growth Properties (NYSE: MGP ) is expected to report quarterly earnings at $0.
   Neurostimulation Devices Market Top Key Players- Medtronic plc, NeuroPace Inc., Nevro Corporation, Neuronetics Inc. Growth Trends, quantitative analysis Industry Analysis and Market Dynamics of the Global Market, 2020 to 2027  2020/10/27 11:13:54 OpenPR
Summary of the Neurostimulation Devices Market Report Due to the various economic, technological, research & development and geographical aspects, the Neurostimulation Devices Market would gain a healthy CAGR and market size from 2020 to 2027. The growth trend would continue to
   Neurostimulation Devices Market Top Key Players- Nevro Corporation, Neuronetics Inc., NeuroSigma, Inc., Synapse Biomedical Inc Growth Trends, quantitative analysis Industry Analysis and Market Dynamics of the Global Market, 2020 to 2027  2020/10/27 11:08:42 OpenPR
Summary of the Neurostimulation Devices Market Report Due to the various economic, technological, research & development and geographical aspects, the Neurostimulation Devices Market would gain a healthy CAGR and market size from 2020 to 2027. The growth trend would
   Brokerages Expect Neuronetics, Inc. (NASDAQ:STIM) Will Post Quarterly Sales of $11.17 Million  2020/10/21 00:52:41 US Banking News
Wall Street brokerages predict that Neuronetics, Inc. (NASDAQ:STIM) will announce $11.17 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Neuronetics’ earnings, with the lowest sales estimate coming in at $10.90 million and the highest estimate coming in at $11.44 million. Neuronetics posted sales of $16.00 […]
   Neuronetics : Supplemental Financial and Operating Information | MarketScreener  2020/08/04 13:07:13 MarketScreener
Neuronetics, Inc. Supplemental Financial and Operating Information For the period ended June 30, 2020 … | August 4, 2020
   The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings  2020/08/02 15:08:50 Benzinga
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in, with big pharma tie-ups flaunting positive tidings. In the biggest ever coronavirus funding deal, the Sanofi SA (NASDAQ: SNY ) GlaxoSmithKline plc (NYSE: GSK ) won a joint $2.1 billion U.S. federal funding award. Here're the key catalysts for the unfolding week: Conferences 72nd National Hemophilia Foundation's Annual Bleeding Disorders Meeting 2020 (virtual meeting): Aug. 1-8 PDUFA Dates FDA is scheduled to rule on DBV TECHNOLOGIE/S' ADR (NASDAQ: DBVT ) Viaskin peanut allergy patch Wednesday. However, cancellation of the Adcom meeting scheduled May 15 has poured cold water on the prospects of an approval coming through. Trevena Inc (NASDAQ: TRVN ) has a tryst with the FDA Friday, with respect to the NDA for its pain drug oleceridine, which was once rejected by the agency on the premise of inadequacy of clinical data.
   Neuronetics (STIM) Reports Q1 Loss, Misses Revenue Estimates  2020/05/05 11:30:04 Zacks Investment Research
Neuronetics (STIM) delivered earnings and revenue surprises of -54.55% and -3.56%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace  2020/05/03 12:45:37 Benzinga
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK ) and Pfizer Inc. (NYSE: PFE ). Merck disappointed by lowering its outlook, although sell-side stayed positive on the prospects. Presentations at the American Association of Cancer Research Virtual Conference created some volatility. Verastem Inc (NASDAQ: VSTM ) became a casualty of "not-so-impressive" clinical data on its Phase 1 asset VS-6766 that targets KRAS mutant advanced solid tumors. The stock shed about 57% to a low of $1.77 before recovering some lost ground. Here are the key catalysts for the unfolding week. Conferences SunTrust Robinson Humphrey 6th Annual Life Sciences Summit (Virtual Conference): May 5–6 Maxim Group M-Vest Infectious Disease Virtual Conference: May 5 Related Link: A Deep Dive On Coronavirus Vaccine Plays Moderna, Inovio Clinical Readouts Adverum Biotechnologies Inc (NASDAQ: ADVM ) is scheduled to present new data from the OPTIC Phase1 clinical trial of ADVM-022 intravitreal gene therapy in wet age-related macular degeneration.
   Insights on the Global Spinal Cord Stimulators Market to 2025 - Featuring Cyberonics, Medtronic & Neuronetics Among Others - ResearchAndMarkets.com  2020/04/30 09:49:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Spinal Cord Stimulators Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. A spinal cord stimulator is a small device that aids in managing the chronic pain in a better way and to reduce the use of opioid medications. SCS may be used as an option for the people suffering from chronic back, leg or arm pain and when optimum results are not received with other therapies such as medication. It is surgically placed under the skin that transfer

calendar